Brief: Finch Expects To Incur $1.1 Million In Costs As Result Of Restructuring
19/04/2022 13:47
April 19 (Reuters) - Finch Therapeutics Group Inc FNCH.O :
* FINCH THERAPEUTICS GROUP INC- AS A RESULT OF THE
RESTRUCTURING,
THE COMPANY ESTIMATES THAT IT WILL INCUR APPROXIMATELY $1.1
MILLION IN COSTS
* FINCH THERAPEUTICS GROUP INC- EXPECTS TO RECORD A
SIGNIFICANT
PORTION OF CHARGES IN THE SECOND QUARTER OF 2022
* FINCH THERAPEUTICS GROUP INC- BELIEVES THE RESTRUCTURING
WILL
ALLOW IT TO FOCUS ITS FINANCIAL RESOURCES ON ITS CDI AND ASD
PROGRAMS
Further company coverage: FNCH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Finch Therapeutics
See all newsFinch wins US jury trial against Ferring over fecal-transplant patents
Brief: Finch Therapeutics Group Received A Notice From Nasdaq Acknowledging Fact That Co Does Not Meet Requirements Of Rules On April 2
Brief: Finch Therapeutics Got Letter From Nasdaq That Co Has Regained Compliance With Nasdaq’s Listing Rule 5450(A)(1)
U.S. STOCKS ON THE MOVE-Gold miners, ImmunoGen, Oracle
U.S. STOCKS ON THE MOVE-Teekay, gold miners, Oil-Dri Corp